APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medication Adherence Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medication Adherence Software Market Outlook and Growth Opportunities 2026

5 June 2026194 pages

Choose your research edition.

Industry ResearchMedication Adherence Software Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Medication Adherence Software Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Medication Adherence Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medication Adherence Software Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Medication Adherence Software Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Medication Adherence Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medication Adherence Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medication Adherence Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medication Adherence Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medication Adherence Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medication Adherence Software market include AARDEX Group, Medisafe, AdhereHealth, McKesson, SMRxT, Surescripts, Dosecast, Agadia Systems and AiCure, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medication Adherence Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medication Adherence Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medication Adherence Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medication Adherence Software market.

Medication Adherence Software Segment by Company

AARDEX Group

Medisafe

AdhereHealth

McKesson

SMRxT

Surescripts

Dosecast

Agadia Systems

AiCure

CleverDev Software

EnlivenHealth

AdhereTech

Medication Adherence Software Segment by Type

Cloud-Based

On-Premises

Medication Adherence Software Segment by Application

Enterprise

Medical Institution

Others

Medication Adherence Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medication Adherence Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medication Adherence Software key companies, revenue, market share, and recent developments.

3. To split the Medication Adherence Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medication Adherence Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medication Adherence Software significant trends, drivers, influence factors in global and regions.

6. To analyze Medication Adherence Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medication Adherence Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medication Adherence Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medication Adherence Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medication Adherence Software industry.

Chapter 3: Detailed analysis of Medication Adherence Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medication Adherence Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medication Adherence Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medication Adherence Software Industry Trends Table 2. Medication Adherence Software Industry Drivers Table 3. Medication Adherence Software Industry Opportunities and Challenges Table 4. Medication Adherence Software Industry Restraints Table 5. Global Medication Adherence Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medication Adherence Software Revenue Share by Company (2021-2026) Table 7. Global Medication Adherence Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medication Adherence Software Key Company Manufacturing Base & Headquarters Table 9. Global Medication Adherence Software Company, Product Type & Application Table 10. Global Medication Adherence Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medication Adherence Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-Based Table 15. Significant Companies of On-Premises Table 16. Global Medication Adherence Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Medication Adherence Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Medication Adherence Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Medication Adherence Software Sales Value Share by Type (2021-2026) Table 20. Global Medication Adherence Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Enterprise Table 22. Significant Companies of Medical Institution Table 23. Significant Companies of Others Table 24. Global Medication Adherence Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Medication Adherence Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Medication Adherence Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Medication Adherence Software Sales Value Share by Application (2021-2026) Table 28. Global Medication Adherence Software Sales Value Share by Application (2027-2032) Table 29. Global Medication Adherence Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Medication Adherence Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Medication Adherence Software Sales Value Share by Region (2021-2026) Table 32. Global Medication Adherence Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Medication Adherence Software Sales Value Share by Region (2027-2032) Table 34. Global Medication Adherence Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Medication Adherence Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Medication Adherence Software Sales Value Market Share by Country (2021-2026) Table 37. Global Medication Adherence Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Medication Adherence Software Sales Value Market Share by Country (2027-2032) Table 39. AARDEX Group Company Information Table 40. AARDEX Group Business Overview Table 41. AARDEX Group Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. AARDEX Group Medication Adherence Software Product Portfolio Table 43. AARDEX Group Recent Development Table 44. Medisafe Company Information Table 45. Medisafe Business Overview Table 46. Medisafe Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Medisafe Medication Adherence Software Product Portfolio Table 48. Medisafe Recent Development Table 49. AdhereHealth Company Information Table 50. AdhereHealth Business Overview Table 51. AdhereHealth Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. AdhereHealth Medication Adherence Software Product Portfolio Table 53. AdhereHealth Recent Development Table 54. McKesson Company Information Table 55. McKesson Business Overview Table 56. McKesson Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. McKesson Medication Adherence Software Product Portfolio Table 58. McKesson Recent Development Table 59. SMRxT Company Information Table 60. SMRxT Business Overview Table 61. SMRxT Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. SMRxT Medication Adherence Software Product Portfolio Table 63. SMRxT Recent Development Table 64. Surescripts Company Information Table 65. Surescripts Business Overview Table 66. Surescripts Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Surescripts Medication Adherence Software Product Portfolio Table 68. Surescripts Recent Development Table 69. Dosecast Company Information Table 70. Dosecast Business Overview Table 71. Dosecast Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Dosecast Medication Adherence Software Product Portfolio Table 73. Dosecast Recent Development Table 74. Agadia Systems Company Information Table 75. Agadia Systems Business Overview Table 76. Agadia Systems Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Agadia Systems Medication Adherence Software Product Portfolio Table 78. Agadia Systems Recent Development Table 79. AiCure Company Information Table 80. AiCure Business Overview Table 81. AiCure Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AiCure Medication Adherence Software Product Portfolio Table 83. AiCure Recent Development Table 84. CleverDev Software Company Information Table 85. CleverDev Software Business Overview Table 86. CleverDev Software Medication Adherence Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CleverDev Software Medication Adherence Software Product Portfolio Table 88. CleverDev Software Recent Development Table 89. EnlivenHealth Company Information Table 90. EnlivenHealth Business Overview Table 91. EnlivenHealth Medication Adherence Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. EnlivenHealth Medication Adherence Software Product Portfolio Table 93. EnlivenHealth Recent Development Table 94. AdhereTech Company Information Table 95. AdhereTech Business Overview Table 96. AdhereTech Medication Adherence Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. AdhereTech Medication Adherence Software Product Portfolio Table 98. AdhereTech Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Medication Adherence Software Product Image Figure 2. Global Medication Adherence Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medication Adherence Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Medication Adherence Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-Based Image Figure 8. On-Premises Image Figure 9. Global Medication Adherence Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Medication Adherence Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Medication Adherence Software Sales Value Share by Type (2021-2032) Figure 12. Enterprise Image Figure 13. Medical Institution Image Figure 14. Others Image Figure 15. Global Medication Adherence Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Medication Adherence Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Medication Adherence Software Sales Value Share by Application (2021-2032) Figure 18. Global Medication Adherence Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Medication Adherence Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Medication Adherence Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Medication Adherence Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Medication Adherence Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Medication Adherence Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Medication Adherence Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Medication Adherence Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Medication Adherence Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Medication Adherence Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Medication Adherence Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Medication Adherence Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Medication Adherence Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Medication Adherence Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Medication Adherence Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based
  • On-Premises
Applications
  • Enterprise
  • Medical Institution
  • Others
Companies covered
  • AARDEX Group
  • Medisafe
  • AdhereHealth
  • McKesson
  • SMRxT
  • Surescripts
  • Dosecast
  • Agadia Systems
  • AiCure
  • CleverDev Software
  • EnlivenHealth
  • AdhereTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medication Adherence Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medication Adherence Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medication Adherence Software Market Dynamics
  1. 2.1 Medication Adherence Software Industry Trends
  2. 2.2 Medication Adherence Software Industry Drivers
  3. 2.3 Medication Adherence Software Industry Opportunities and Challenges
  4. 2.4 Medication Adherence Software Industry Restraints
3 Medication Adherence Software Market by Company
  1. 3.1 Global Medication Adherence Software Company Revenue Ranking in 2025
  2. 3.2 Global Medication Adherence Software Revenue by Company (2021-2026)
  3. 3.3 Global Medication Adherence Software Company Ranking (2024-2026)
  4. 3.4 Global Medication Adherence Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Medication Adherence Software Company Product Type and Application
  6. 3.6 Global Medication Adherence Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medication Adherence Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medication Adherence Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medication Adherence Software Market by Type
  1. 4.1 Medication Adherence Software Type Introduction
  2. 4.1.1 Cloud-Based
  3. 4.1.2 On-Premises
  4. 4.2 Global Medication Adherence Software Sales Value by Type
  5. 4.2.1 Global Medication Adherence Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Medication Adherence Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Medication Adherence Software Sales Value Share by Type (2021-2032)
5 Medication Adherence Software Market by Application
  1. 5.1 Medication Adherence Software Application Introduction
  2. 5.1.1 Enterprise
  3. 5.1.2 Medical Institution
  4. 5.1.3 Others
  5. 5.2 Global Medication Adherence Software Sales Value by Application
  6. 5.2.1 Global Medication Adherence Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medication Adherence Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Medication Adherence Software Sales Value Share by Application (2021-2032)
6 Medication Adherence Software Regional Value Analysis
  1. 6.1 Global Medication Adherence Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medication Adherence Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medication Adherence Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medication Adherence Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medication Adherence Software Sales Value (2021-2032)
  7. 6.3.2 North America Medication Adherence Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medication Adherence Software Sales Value (2021-2032)
  10. 6.4.2 Europe Medication Adherence Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medication Adherence Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medication Adherence Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medication Adherence Software Sales Value (2021-2032)
  16. 6.6.2 South America Medication Adherence Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medication Adherence Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medication Adherence Software Sales Value Share by Country, 2025 VS 2032
7 Medication Adherence Software Country-level Value Analysis
  1. 7.1 Global Medication Adherence Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medication Adherence Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medication Adherence Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medication Adherence Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medication Adherence Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medication Adherence Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medication Adherence Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medication Adherence Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medication Adherence Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medication Adherence Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medication Adherence Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medication Adherence Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medication Adherence Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medication Adherence Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medication Adherence Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medication Adherence Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medication Adherence Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medication Adherence Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medication Adherence Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medication Adherence Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medication Adherence Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medication Adherence Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medication Adherence Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medication Adherence Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medication Adherence Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medication Adherence Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medication Adherence Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medication Adherence Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medication Adherence Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medication Adherence Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medication Adherence Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medication Adherence Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medication Adherence Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medication Adherence Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AARDEX Group
  2. 8.1.1 AARDEX Group Company Information
  3. 8.1.2 AARDEX Group Business Overview
  4. 8.1.3 AARDEX Group Medication Adherence Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AARDEX Group Medication Adherence Software Product Portfolio
  6. 8.1.5 AARDEX Group Recent Developments
  7. 8.2 Medisafe
  8. 8.2.1 Medisafe Company Information
  9. 8.2.2 Medisafe Business Overview
  10. 8.2.3 Medisafe Medication Adherence Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medisafe Medication Adherence Software Product Portfolio
  12. 8.2.5 Medisafe Recent Developments
  13. 8.3 AdhereHealth
  14. 8.3.1 AdhereHealth Company Information
  15. 8.3.2 AdhereHealth Business Overview
  16. 8.3.3 AdhereHealth Medication Adherence Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AdhereHealth Medication Adherence Software Product Portfolio
  18. 8.3.5 AdhereHealth Recent Developments
  19. 8.4 McKesson
  20. 8.4.1 McKesson Company Information
  21. 8.4.2 McKesson Business Overview
  22. 8.4.3 McKesson Medication Adherence Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 McKesson Medication Adherence Software Product Portfolio
  24. 8.4.5 McKesson Recent Developments
  25. 8.5 SMRxT
  26. 8.5.1 SMRxT Company Information
  27. 8.5.2 SMRxT Business Overview
  28. 8.5.3 SMRxT Medication Adherence Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SMRxT Medication Adherence Software Product Portfolio
  30. 8.5.5 SMRxT Recent Developments
  31. 8.6 Surescripts
  32. 8.6.1 Surescripts Company Information
  33. 8.6.2 Surescripts Business Overview
  34. 8.6.3 Surescripts Medication Adherence Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Surescripts Medication Adherence Software Product Portfolio
  36. 8.6.5 Surescripts Recent Developments
  37. 8.7 Dosecast
  38. 8.7.1 Dosecast Company Information
  39. 8.7.2 Dosecast Business Overview
  40. 8.7.3 Dosecast Medication Adherence Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dosecast Medication Adherence Software Product Portfolio
  42. 8.7.5 Dosecast Recent Developments
  43. 8.8 Agadia Systems
  44. 8.8.1 Agadia Systems Company Information
  45. 8.8.2 Agadia Systems Business Overview
  46. 8.8.3 Agadia Systems Medication Adherence Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Agadia Systems Medication Adherence Software Product Portfolio
  48. 8.8.5 Agadia Systems Recent Developments
  49. 8.9 AiCure
  50. 8.9.1 AiCure Company Information
  51. 8.9.2 AiCure Business Overview
  52. 8.9.3 AiCure Medication Adherence Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AiCure Medication Adherence Software Product Portfolio
  54. 8.9.5 AiCure Recent Developments
  55. 8.10 CleverDev Software
  56. 8.10.1 CleverDev Software Company Information
  57. 8.10.2 CleverDev Software Business Overview
  58. 8.10.3 CleverDev Software Medication Adherence Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CleverDev Software Medication Adherence Software Product Portfolio
  60. 8.10.5 CleverDev Software Recent Developments
  61. 8.11 EnlivenHealth
  62. 8.11.1 EnlivenHealth Company Information
  63. 8.11.2 EnlivenHealth Business Overview
  64. 8.11.3 EnlivenHealth Medication Adherence Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 EnlivenHealth Medication Adherence Software Product Portfolio
  66. 8.11.5 EnlivenHealth Recent Developments
  67. 8.12 AdhereTech
  68. 8.12.1 AdhereTech Company Information
  69. 8.12.2 AdhereTech Business Overview
  70. 8.12.3 AdhereTech Medication Adherence Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AdhereTech Medication Adherence Software Product Portfolio
  72. 8.12.5 AdhereTech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst